A Comprehensive Review of Systemic Sclerosis: Diagnosis, Clinical Features and Management Strategies
Authors:
- Agnieszka BorowiecABAgnieszka Borowiec
- Kinga BorowiecKBKinga Borowiec
- Paulina KwaśniewskaPKPaulina Kwaśniewska
- Julia BiernikiewiczJBJulia Biernikiewicz
- Milena BiernikiewiczMBMilena Biernikiewicz
- Anna WilewskaAWAnna Wilewska
- Bartosz PomirskiBPBartosz Pomirski
- Agata PomirskaAPAgata Pomirska
- Konstanty AlabrudzińskiKAKonstanty Alabrudziński
- Miszela KałachurskaMKMiszela Kałachurska
Open Access
- 18 February 2025
- journal article
- review article
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 78, 57679
Abstract
Introduction Systemic sclerosis (SSc) is a rare autoimmune disease characterized by fibrosis of the skin and internal organs, along with vasculopathy. It is associated with significant morbidity and mortality, particularly due to pulmonary and renal complications. Early diagnosis is challenging, but crucial, as severe internal organ involvement can occur within three years of disease onset. SSc is categorized into subsets, such as diffuse and limited cutaneous forms with varying degrees of skin and organ involvement. Specific autoantibodies are critical for diagnosing and predicting disease severity and understanding these serological profiles aids in personalized treatment decisions. Management focuses on addressing specific manifestations like Raynaud’s phenomenon, skin fibrosis, pulmonary involvement, and gastrointestinal issues with treatment strategies tailored to the disease’s stage and organ involvement. Despite advances in treatment, SSc remains a challenging disease requiring ongoing vigilance for early detection and intervention. Purpose The purpose of this article is to provide a comprehensive overview of systemic sclerosis, focusing on its diagnostic criteria, clinical features and management strategies. It aimsto highlight the importance of early detection, particularly in the context of skin and organ involvement and the role of serological markers in guiding diagnosis and treatment. Ultimately, the goal is to improve awareness and understanding of SSc among healthcare professionals, particularly dermatologists, to enhance early diagnosis and optimize patient outcomes. Materials and Methods Our review is based on an analysis of material collected in 'Pubmed', 'Google Scholar' and other scientific articles using the keywords: systemic sclerosis, antinuclear antibodies, Raynaud’s phenomenon, pulmonary arterial hypertension.Keywords
This publication has 70 references indexed in Scilit:
- Racial Disparities in Systemic Sclerosis: Short‐ and Long‐Term Outcomes Among African American Participants of SLS I and IIACR Open Rheumatology, 2020
- Increased Morbidity and Mortality of Scleroderma in African Americans Compared to Non–African AmericansArthritis Care & Research, 2019
- Determining the Risk Factors and Clinical Features Associated With Severe Gastrointestinal Dysmotility in Systemic SclerosisArthritis Care & Research, 2018
- Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic SclerosisArthritis Care & Research, 2017
- Predictive Value of Serial High‐Resolution Computed Tomography Analyses and Concurrent Lung Function Tests in Systemic SclerosisArthritis & Rheumatology, 2015
- Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic SclerosisJAMA, 2014
- Survival and Predictors of Mortality in Systemic Sclerosis‐Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma RegistryArthritis Care & Research, 2013
- Calcinosis Cutis Occurring in Association With Autoimmune Connective Tissue DiseaseArchives of Dermatology, 2012
- Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty‐year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosisArthritis & Rheumatism, 2008
- Digital ulcers in systemic sclerosis: Prevention by treatment with bosentan, an oral endothelin receptor antagonistArthritis & Rheumatism, 2004